<p><strong>在本次免費網絡研討會中，瞭解如何提高細胞系開發中的單克隆性保證。與會者將獲得通過納米液滴和全孔明場成像來最小化假陽性（幽靈孔）風險的實用方法的見解。主講人將分享利用熒光全孔成像驗證 99.99% 單克隆性概率工作流程的關鍵策略。與會者將理解人工智能和數據集中化如何將圖像分析的全職員工需求減少超過 50%。</strong></p>
<p>, /PRNewswire/ -- 確保穩定的細胞系源自單一祖細胞是蛋白質、細胞和基因療法開發的基本組成部分。然而，單克隆性保證往往是細胞系開發中的一個限制性步驟，導致項目延遲和風險增加。</p>
<p>繼續閲讀</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>http://www.novabiomedical.com/</p>
<p>在演講中，Nova Biomedical 的 Solentim 產品組合全球產品經理 Adam Causer 將提供一個端到端工作流程的概述，該流程不僅實現 99.99% 的單克隆性概率，還數字化和自動化生成 IND 提交單克隆性證據的過程。</p>
<p>與會者將獲得可操作的見解，以最小化幽靈孔風險，使用温和的自動化單細胞沉積，並概述如何在結合高通量全孔成像時實現能夠提供超過 99.99% 單克隆性概率的工作流程——在使用人工智能驅動的數據管理和分析的情況下，不犧牲通量或效率。</p>
<p>請於 2026 年 2 月 24 日（星期二）參加網絡研討會，屆時將進行兩次直播，分別在中歐時間上午 9 點（中國時間下午 4 點）和北美東部時間上午 8 點（中歐時間下午 2 點）。</p>
<p>有關更多信息或註冊此活動，請訪問《提高細胞系開發中的單克隆性保證：在第 0 天看到更多》。</p>
<p><strong>關於 XTALKS</strong></p>
<p>Xtalks — 生命科學社區™ 賦能製藥、生物技術、醫療技術、醫療保健和研究領域的專業人士，提供可信的知識和協作見解，推動行業向前發展。由 Honeycomb Worldwide Inc.提供支持，Xtalks 提供新聞、特寫文章、網絡研討會、播客、視頻、專家訪談、精心策劃的工作機會等，旨在支持在快速發展的行業中做出明智的決策。</p>
<p>每年，成千上萬的專業人士依賴 Xtalks 獲取及時的信息、同行觀點和行業思想領導力。加入我們的生命科學社區，保持信息靈通、互聯互通，併為未來做好準備。</p>
<p>要了解更多關於 Xtalks 的信息，請訪問 www.xtalks.com</p>
<p>有關與 Xtalks 合作舉辦網絡研討會的信息，請訪問 https://xtalks.com/partner-with-us/</p>
<p>聯繫方式：</p>
<p>Vera Kovacevic</p>
<p>電話：+1 (416) 977-6555 x371</p>
<p>電子郵件：[email protected]</p>
<p>來源：Xtalks</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjA0Jk5ld3NJdGVtSWQ9Tlk3NTU0MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDQwODMwUFJfTkVXU19VU1BSX19fX19OWTc1NTQx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjA0Jk5ld3NJdGVtSWQ9Tlk3NTU0MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDQwODMwUFJfTkVXU19VU1BSX19fX19OWTc1NTQx"/></p>

<p>Xtalks 將於 2026 年 2 月 24 日舉辦一場免費的網絡研討會，重點討論在細胞系開發中增強單克隆性保障。會議將涵蓋減少假陽性和利用先進成像技術及人工智能實現 99.99% 克隆概率的策略。來自 Nova Biomedical 的 Adam Causer 將展示一個自動化生成 IND 提交證據的端到端工作流程。與會者將學習如何減少圖像分析中的全職員工需求，並提高細胞系開發的效率</p>

<p><strong>In this free webinar, learn how to improve monoclonality assurance in cell line development. Attendees will gain insight into practical ways to minimize false positive (ghost well) risk through nanodroplet and whole well brightfield imaging. The featured speaker will share key strategies for validating a workflow with 99.99% Probability of Clonality utilizing fluorescence whole well imaging. Attendees will understand how artificial intelligence and data centralization can reduce FTE demands of image analysis by over 50%.</strong></p>
<div class="lb-trans"><p><strong>在本次免費網絡研討會中，瞭解如何提高細胞系開發中的單克隆性保證。與會者將獲得通過納米液滴和全孔明場成像來最小化假陽性（幽靈孔）風險的實用方法的見解。主講人將分享利用熒光全孔成像驗證 99.99% 單克隆性概率工作流程的關鍵策略。與會者將理解人工智能和數據集中化如何將圖像分析的全職員工需求減少超過 50%。</strong></p>
</div><p>, /PRNewswire/ -- Assuring that a stable cell line originates from a single progenitor cell is a fundamental component of the development of protein, cellular and gene therapies. However, monoclonality assurance is often a rate-limiting step in cell line development, leading to project delays and increased risk.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- 確保穩定的細胞系源自單一祖細胞是蛋白質、細胞和基因療法開發的基本組成部分。然而，單克隆性保證往往是細胞系開發中的一個限制性步驟，導致項目延遲和風險增加。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>繼續閲讀</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>http://www.novabiomedical.com/</p>
<div class="lb-trans"><p>http://www.novabiomedical.com/</p>
</div><p>During the presentation, Adam Causer, Global Product Manager, Solentim Portfolio, Nova Biomedical, will provide an overview of an end-to-end workflow that not only achieves 99.99% probability of clonality but also digitalizes and automates the process of generating evidence of clonality for IND submissions.</p>
<div class="lb-trans"><p>在演講中，Nova Biomedical 的 Solentim 產品組合全球產品經理 Adam Causer 將提供一個端到端工作流程的概述，該流程不僅實現 99.99% 的單克隆性概率，還數字化和自動化生成 IND 提交單克隆性證據的過程。</p>
</div><p>Attendees will gain actionable insights into minimizing ghost well risk using gentle, automated single‑cell deposition, and an overview of how to achieve workflows capable of delivering greater than 99.99% Probability of Clonality when combined with high‑throughput whole‑well imaging — without sacrificing throughput or efficiency through the use of AI‑powered data management and analytics.</p>
<div class="lb-trans"><p>與會者將獲得可操作的見解，以最小化幽靈孔風險，使用温和的自動化單細胞沉積，並概述如何在結合高通量全孔成像時實現能夠提供超過 99.99% 單克隆性概率的工作流程——在使用人工智能驅動的數據管理和分析的情況下，不犧牲通量或效率。</p>
</div><p>Join the webinar on Tuesday, February 24, 2026 with 2 live broadcasts, at 9am CET/EU-Central (4pm CST/China) and at 8am EST/N. America (2pm CET/EU-Central).</p>
<div class="lb-trans"><p>請於 2026 年 2 月 24 日（星期二）參加網絡研討會，屆時將進行兩次直播，分別在中歐時間上午 9 點（中國時間下午 4 點）和北美東部時間上午 8 點（中歐時間下午 2 點）。</p>
</div><p>For more information, or to register for this event, visit Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0.</p>
<div class="lb-trans"><p>有關更多信息或註冊此活動，請訪問《提高細胞系開發中的單克隆性保證：在第 0 天看到更多》。</p>
</div><p><strong>ABOUT XTALKS</strong></p>
<div class="lb-trans"><p><strong>關於 XTALKS</strong></p>
</div><p>Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.</p>
<div class="lb-trans"><p>Xtalks — 生命科學社區™ 賦能製藥、生物技術、醫療技術、醫療保健和研究領域的專業人士，提供可信的知識和協作見解，推動行業向前發展。由 Honeycomb Worldwide Inc.提供支持，Xtalks 提供新聞、特寫文章、網絡研討會、播客、視頻、專家訪談、精心策劃的工作機會等，旨在支持在快速發展的行業中做出明智的決策。</p>
</div><p>Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.</p>
<div class="lb-trans"><p>每年，成千上萬的專業人士依賴 Xtalks 獲取及時的信息、同行觀點和行業思想領導力。加入我們的生命科學社區，保持信息靈通、互聯互通，併為未來做好準備。</p>
</div><p>To learn more about Xtalks, visit www.xtalks.com</p>
<div class="lb-trans"><p>要了解更多關於 Xtalks 的信息，請訪問 www.xtalks.com</p>
</div><p>For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/</p>
<div class="lb-trans"><p>有關與 Xtalks 合作舉辦網絡研討會的信息，請訪問 https://xtalks.com/partner-with-us/</p>
</div><p>Contact:</p>
<div class="lb-trans"><p>聯繫方式：</p>
</div><p>Vera Kovacevic</p>
<div class="lb-trans"><p>Vera Kovacevic</p>
</div><p>Tel: +1 (416) 977-6555 x371</p>
<div class="lb-trans"><p>電話：+1 (416) 977-6555 x371</p>
</div><p>Email: [email protected]</p>
<div class="lb-trans"><p>電子郵件：[email protected]</p>
</div><p>SOURCE Xtalks</p>
<div class="lb-trans"><p>來源：Xtalks</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjA0Jk5ld3NJdGVtSWQ9Tlk3NTU0MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDQwODMwUFJfTkVXU19VU1BSX19fX19OWTc1NTQx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY75541&amp;Transmission_Id=202602040830PR_NEWS_USPR_____NY75541&amp;DateId=20260204"/></p>

08:30 ET 提高細胞系開發中的單克隆性保證：在第 0 天看到更多，Xtalks 即將舉辦的網絡研討會